Flowerbx Limited – Trademark Portfolio
Entity Type: 99
Flowerbx Limited holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 4 (Lubricants & Fuels) across 6 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include FLOWERBX. The owner is based in London.
42 Gorst Road
London NW106LD , GB
Showing of trademarks Trademarks
Trademark Classifications
Flowerbx Limited's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Flowerbx Limited have?
Flowerbx Limited has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Flowerbx Limited file in?
Flowerbx Limited files trademarks across 6 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 4 (Lubricants & Fuels), Class 31 (Natural Agricultural Products), Class 8 (Hand Tools), Class 21 (Housewares). Class 35 covers advertising; business management; business administration; office functions.
What are Flowerbx Limited's most well-known trademarks?
Flowerbx Limited's registered trademark portfolio includes well-known marks such as FLOWERBX. These are among 3 currently registered trademarks in the portfolio.
What is Flowerbx Limited's trademark registration success rate?
Flowerbx Limited has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.